Procyon Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.71M | Sell |
25,392
-6,771
| -21% | -$1.26M | 0.44% | 52 |
|
|
2025
Q1 | $6.74M | Buy |
32,163
+4,302
| +15% | +$901K | 0.41% | 57 |
|
|
2024
Q4 | $4.95M | Buy |
27,861
+214
| +0.8% | +$38K | 0.31% | 71 |
|
|
2024
Q3 | $5.46M | Sell |
27,647
-1,227
| -4% | -$242K | 0.37% | 59 |
|
|
2024
Q2 | $4.95M | Buy |
28,874
+798
| +3% | +$137K | 0.37% | 60 |
|
|
2024
Q1 | $5.11M | Sell |
28,076
-2,112
| -7% | -$385K | 0.4% | 61 |
|
|
2023
Q4 | $4.68M | Sell |
30,188
-924
| -3% | -$143K | 0.4% | 56 |
|
|
2023
Q3 | $4.64M | Buy |
31,112
+2,811
| +10% | +$419K | 0.48% | 49 |
|
|
2023
Q2 | $3.81M | Sell |
28,301
-1,495
| -5% | -$201K | 0.48% | 48 |
|
|
2023
Q1 | $4.75M | Buy |
29,796
+563
| +2% | +$89.7K | 0.79% | 29 |
|
|
2022
Q4 | $4.72M | Buy |
29,233
+4,287
| +17% | +$693K | 0.87% | 25 |
|
|
2022
Q3 | $3.35M | Sell |
24,946
-3,210
| -11% | -$431K | 0.82% | 24 |
|
|
2022
Q2 | $4.31M | Sell |
28,156
-5,675
| -17% | -$869K | 0.95% | 22 |
|
|
2022
Q1 | $5.48M | Buy |
33,831
+1,898
| +6% | +$308K | 1.13% | 16 |
|
|
2021
Q4 | $4.32M | Buy |
31,933
+2,280
| +8% | +$309K | 0.92% | 21 |
|
|
2021
Q3 | $3.2M | Buy |
29,653
+1,920
| +7% | +$207K | 0.82% | 28 |
|
|
2021
Q2 | $3.12M | Buy |
27,733
+8,617
| +45% | +$971K | 0.85% | 29 |
|
|
2021
Q1 | $2.07M | Buy |
19,116
+238
| +1% | +$25.8K | 0.92% | 25 |
|
|
2020
Q4 | $2.02M | Buy |
18,878
+1,066
| +6% | +$114K | 0.99% | 23 |
|
|
2020
Q3 | $1.56M | Buy |
17,812
+12
| +0.1% | +$1.05K | 0.87% | 29 |
|
|
2020
Q2 | $1.75M | Buy |
17,800
+962
| +6% | +$94.5K | 0.93% | 25 |
|
|
2020
Q1 | $1.28M | Buy |
16,838
+2,753
| +20% | +$210K | 0.85% | 29 |
|
|
2019
Q4 | $1.25M | Buy |
+14,085
| New | +$1.25M | 0.76% | 33 |
|